Coherus Oncology, Inc.CHRSNASDAQ
Loading
Net Margin Over TimeContracting
Percentile Rank38
Studio
Year-over-Year Change

Net income as a percentage of revenue

Percentile
P38
Within normal range
vs 5Y Ago
-14.5x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM-403.80%-3881.5%
202410.68%+111.5%
2023-92.48%+33.1%
2022-138.24%-57.2%
2021-87.92%-416.3%
202027.79%+10.2%
201925.23%+100.2%
2018-13453.66%+12.1%
2017-15306.56%-22751.7%
2016-66.98%-